Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors-Reference-Cited by-同舟云学术

Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors

Published:2014-12-03 Issue:12 Volume:9 Page:e114249
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

McGraw Kathy L.,Basiorka Ashley A.,Johnson Joseph O.,Clark Justine,Caceres Gisela,Padron Eric,Heaton Ruth,Ozawa Yukiyasu,Wei Sheng,Sokol Lubomir,List Alan F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome;LH Hoefsloot;Blood,1997

2. An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome;BL Ebert;PLoS medicine,2008

3. The reduced GM-CSF priming of ROS production in granulocytes from patients with myelodysplasia is associated with an impaired lipid raft formation;GM Fuhler;Journal of leukocyte biology,2007

4. Erythropoietin receptor signaling is membrane raft dependent;KL McGraw;PloS one,2012

5. Membrane compartmentation is required for efficient T cell activation;R Xavier;Immunity,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining lenalidomide with erythropoiesis stimulating agents: a party of one;Leukemia;2024-02-15

2. Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial;Leukemia;2024-01-31

3. Location, location, location: Protein kinase nanoclustering for optimised signalling output;eLife;2024-01-11

4. Myelodysplastic Syndrome;Comprehensive Hematology and Stem Cell Research;2024

5. Location, Location, Location: Protein kinase nanoclustering for optimized signalling output;2023-09-29